Advanced Search

Study Preview



Study Title and Description

Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs.



Key Questions Addressed
9 Key Question 9. What is the association between experiencing SVR following antiviral treatment and reduction in risk of HCV-related adverse health outcomes?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Assessment of hepatocellular carcinoma risk based on peg-interferon plus ribavirin treatment experience in this new era of highly effective oral antiviral drugs.
Author Lee SH., Jin YJ., Shin JY., Lee JW.
Country Department of Internal Medicine, Inha University Hospital, Inha University School of Medicine, Incheon, South Korea.
Year 2017
Numbers Pubmed ID: 28072684

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Key Questions 1-9


Results & Comparisons

No Results found.